TRCT
CNTB

Tower Research Capital (TRC)’s Connect Biopharma Holdings CNTB Stock Holding History

Tower Research Capital (TRC)’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1K Buy
+882
New +$2.14K ﹤0.01% 4720
2023
Q1 		– Sell
-10,398
Closed -$9K – 5863
2022
Q4 		$9K Sell
10,398
-5,812
-36% -$4.79K ﹤0.01% 4177
2022
Q3 		$21K Sell
16,210
-615
-4% -$739 ﹤0.01% 3889
2022
Q2 		$15K Buy
16,825
+15,584
+1,256% +$23K ﹤0.01% 4061
2022
Q1 		$4K Buy
+1,241
New +$5.24K ﹤0.01% 5187

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Tower Research Capital (TRC)'s CNTB Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 882 shares worth $2.1K. The stake represents ﹤0.01% of the portfolio and ranks #4720 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in CNTB as recently as Q4 2022.

Tower Research Capital (TRC) first reported a position in CNTB in Q1 2022 and has held it in 5 quarters since. The position peaked at $21K in Q3 2022. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Tower Research Capital (TRC) held 882 shares of Connect Biopharma Holdings worth $2.1K as of Q2 2026.
  • Connect Biopharma Holdings was a new Tower Research Capital (TRC) position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4720 holding.
  • Tower Research Capital (TRC) first reported a position in Connect Biopharma Holdings in Q1 2022 and has held it in 5 quarters since.
  • Tower Research Capital (TRC)'s Connect Biopharma Holdings position peaked at $21K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.